scholarly article | Q13442814 |
P50 | author | Els Goulmy | Q1965129 |
Edus H Warren | Q37842175 | ||
Stephen Spellman | Q111077182 | ||
P2093 | author name string | Tao Wang | |
Michael Haagenson | |||
Bradley C Pietz | |||
Thomas M Ellis | |||
Melissa B Warden | |||
P2860 | cites work | Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens | Q24673417 |
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing | Q24675797 | ||
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein | Q28187004 | ||
Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. | Q30179443 | ||
A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. | Q30274634 | ||
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. | Q30307859 | ||
UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. | Q33922834 | ||
Molecules and mechanisms of the graft-versus-leukaemia effect | Q34318010 | ||
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation | Q34582448 | ||
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia | Q34808353 | ||
The current status of hematopoietic cell transplantation | Q34987985 | ||
The immunogenomics of minor histocompatibility antigens. | Q35030963 | ||
Multiplexed genetic analysis using an expanded genetic alphabet | Q35070311 | ||
Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations | Q35865440 | ||
Using expanded genetic alphabets to simplify high-throughput genetic testing | Q36411692 | ||
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. | Q41061835 | ||
Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation | Q41537736 | ||
Much ado about minor histocompatibility antigens | Q41737638 | ||
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen | Q44370136 | ||
CD31 mismatching affects marrow transplantation outcome. | Q45936737 | ||
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome | Q47359749 | ||
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 | ||
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leu | Q57219125 | ||
Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells | Q68321746 | ||
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation | Q68809214 | ||
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
Isolation of an HLA-A2.1 extracted human minor histocompatibility peptide | Q70599533 | ||
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation | Q70812614 | ||
Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact | Q72656176 | ||
Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation | Q73070294 | ||
DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection | Q73386767 | ||
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT) | Q73876956 | ||
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities | Q73877066 | ||
The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation | Q80860433 | ||
Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation | Q81490638 | ||
Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation | Q81579273 | ||
Multiplex genotyping of human minor histocompatibility antigens | Q83003340 | ||
P433 | issue | 7 | |
P921 | main subject | stem cell transplantation | Q65592366 |
P304 | page(s) | 856-863 | |
P577 | publication date | 2009-07-01 | |
P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
P1476 | title | Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants | |
P478 | volume | 15 |
Q36279223 | Association between genetic variants in adhesion molecules and outcomes after hematopoietic cell transplants |
Q39425522 | Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II-IV acute GvHD: a systematic review and meta-analysis |
Q36556944 | Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation |
Q38123020 | Biologic markers of chronic GVHD. |
Q35094374 | Biomarkers in chronic graft-versus-host disease |
Q37014401 | CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. |
Q38021811 | Developments in the prevention of transfusion-associated graft-versus-host disease |
Q34393959 | Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells? |
Q37114320 | Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor-Recipient Pairs. |
Q36305321 | Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT |
Q42432554 | Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation |
Q39263959 | From genetic single candidate gene studies to complex genomics of GvHD. |
Q34771143 | Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation |
Q35794126 | HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection |
Q98906910 | Human immunology and immunotherapy: main achievements and challenges |
Q38171067 | Immunotherapeutic approaches to treat multiple myeloma |
Q34462528 | In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation |
Q43434851 | Increased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion |
Q38616461 | Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives |
Q43547709 | Minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: frequency and application in hematopoietic stem cell transplantation |
Q38254976 | Minor histocompatibility antigens: past, present, and future. |
Q39445130 | Mismatch for the minor histocompatibility antigen HA-2 and GVHD occurrence in HLA-A*0201-positive Tunisian recipients of HSCs. |
Q34044024 | NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr |
Q35969119 | One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing |
Q42699915 | Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor |
Q51536134 | The impact of H-Y mismatches on results of HLA-matched unrelated allogeneic hematopoietic stem cell transplantation. |
Q35153382 | Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation |